This post-translational modification of the acyl carrier protein is essential for the functional maturation of FASN. The third enzyme of lipid biosynthesis pathway down-regulated by let-7a is a fatty acid desaturase SCD, which is also shown to be involved in cancer progression and considered to be an attractive target for anticancer therapy [39, 40]. Here, SCD is linked to cancer.